Search Results - "Journal of thrombosis and haemostasis"

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia by Tang, Ning, Li, Dengju, Wang, Xiong, Sun, Ziyong

“…Background In the recent outbreak of novel coronavirus infection in Wuhan, China, significantly abnormal coagulation parameters in severe novel coronavirus…”
Get full text

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy by Tang, Ning, Bai, Huan, Chen, Xing, Gong, Jiale, Li, Dengju, Sun, Ziyong

“…Background A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been…”
Get full text

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia by Cui, Songping, Chen, Shuo, Li, Xiunan, Liu, Shi, Wang, Feng

“…Background Three months ago, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) broke out in Wuhan, China, and spread rapidly around the world…”
Get full text

Incidence of venous thromboembolism in hospitalized patients with COVID‐19 by Middeldorp, Saskia, Coppens, Michiel, Haaps, Thijs F., Foppen, Merijn, Vlaar, Alexander P., Müller, Marcella C. A., Bouman, Catherine C. S., Beenen, Ludo F. M., Kootte, Ruud S., Heijmans, Jarom, Smits, Loek P., Bonta, Peter I., Es, Nick

“…Background Coronavirus disease 2019 (COVID‐19) can lead to systemic coagulation activation and thrombotic complications. Objectives To investigate the…”
Get full text

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 by Thachil, Jecko, Tang, Ning, Gando, Satoshi, Falanga, Anna, Cattaneo, Marco, Levi, Marcel, Clark, Cary, Iba, Toshiaki

Get full text

Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis by Panigada, Mauro, Bottino, Nicola, Tagliabue, Paola, Grasselli, Giacomo, Novembrino, Cristina, Chantarangkul, Veena, Pesenti, Antonio, Peyvandi, Flora, Tripodi, Armando

“…Background The severe inflammatory state secondary to COVID‐19 leads to a severe derangement of hemostasis that has been recently described as a state of…”
Get full text

High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients by Llitjos, Jean‐François, Leclerc, Maxime, Chochois, Camille, Monsallier, Jean‐Michel, Ramakers, Michel, Auvray, Malika, Merouani, Karim

“…Background Coagulopathy is a common abnormality in patients with COVID‐19. However, the exact incidence of venous thromboembolic event is unknown in…”
Get full text

D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19 by Zhang, Litao, Yan, Xinsheng, Fan, Qingkun, Liu, Haiyan, Liu, Xintian, Liu, Zejin, Zhang, Zhenlu

“…Background The outbreak of the coronavirus disease 2019 (Covid‐19) has shown a global spreading trend. Early and effective predictors of clinical outcomes are…”
Get full text

The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome by Ranucci, Marco, Ballotta, Andrea, Di Dedda, Umberto, Bayshnikova, Ekaterina, Dei Poli, Marco, Resta, Marco, Falco, Mara, Albano, Giovanni, Menicanti, Lorenzo

“…Background Few observations exist with respect to the pro‐coagulant profile of patients with COVID‐19 acute respiratory distress syndrome (ARDS). Reports of…”
Get full text

Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19 by Spyropoulos, Alex C., Levy, Jerrold H., Ageno, Walter, Connors, Jean Marie, Hunt, Beverley J., Iba, Toshiaki, Levi, Marcel, Samama, Charles Marc, Thachil, Jecko, Giannis, Dimitrios, Douketis, James D.

Get full text

Coagulopathy in COVID‐19 by Iba, Toshiaki, Levy, Jerrold H., Levi, Marcel, Thachil, Jecko

“…The COVID‐19 pandemic has become an urgent issue in every country. Based on recent reports, the most severely ill patients present with coagulopathy, and…”
Get full text

DOACs and “newer” hemophilia therapies in COVID‐19: Reply by Thachil, Jecko, Tang, Ning, Gando, Satoshi, Falanga, Anna, Cattaneo, Marco, Levi, Marcel, Clark, Cary, Iba, Toshiaki

Get full text

Thromboinflammation and the hypercoagulability of COVID‐19 by Connors, Jean M., Levy, Jerrold H.

Get full text

Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series by Wang, Janice, Hajizadeh, Negin, Moore, Ernest E., McIntyre, Robert C., Moore, Peter K., Veress, Livia A., Yaffe, Michael B., Moore, Hunter B., Barrett, Christopher D.

“…A prothrombotic coagulopathy is commonly found in critically ill COVID‐19 patients with acute respiratory distress syndrome (ARDS). A unique feature of…”
Get full text

Pathological evidence of pulmonary thrombotic phenomena in severe COVID‐19 by Dolhnikoff, Marisa, Duarte‐Neto, Amaro Nunes, Almeida Monteiro, Renata Aparecida, Silva, Luiz Fernando Ferraz, Oliveira, Ellen Pierre, Saldiva, Paulo Hilário Nascimento, Mauad, Thais, Negri, Elnara Marcia

Get full text

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial by McBane, Robert D., Wysokinski, Waldemar E., Le‐Rademacher, Jennifer G., Zemla, Tyler, Ashrani, Aneel, Tafur, Alfonso, Perepu, Usha, Anderson, Daniel, Gundabolu, Krishna, Kuzma, Charles, Perez Botero, Juliana, Leon Ferre, Roberto A., Henkin, Stanislav, Lenz, Charles J., Houghton, Damon E., Vishnu, Prakash, Loprinzi, Charles L.

“…Background Low‐molecular‐weight heparin is the guideline‐endorsed treatment for cancer‐associated venous thromboembolism (VTE). While apixaban is approved for…”
Get full text

Thrombocytopenia and its association with mortality in patients with COVID‐19 by Yang, Xiaobo, Yang, Qingyu, Wang, Yaxin, Wu, Yongran, Xu, Jiqian, Yu, Yuan, Shang, You

“…Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes novel coronavirus disease 2019 (COVID‐19), is spreading rapidly around…”
Get full text

Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation by Devreese, Katrien M J, de Groot, Philip G, de Laat, Bas, Erkan, Doruk, Favaloro, Emmanuel J, Mackie, Ian, Martinuzzo, Marta, Ortel, Thomas L, Pengo, Vittorio, Rand, Jacob H, Tripodi, Armando, Wahl, Denis, Cohen, Hannah

“…This guidance focuses on methodological aspects of lupus anticoagulant (LA) testing, as well as interpretation of results for clinicians. The main changes in…”
Get full text

Persistent endotheliopathy in the pathogenesis of long COVID syndrome by Fogarty, Helen, Townsend, Liam, Morrin, Hannah, Ahmad, Azaz, Comerford, Claire, Karampini, Ellie, Englert, Hanna, Byrne, Mary, Bergin, Colm, O’Sullivan, Jamie M., Martin‐Loeches, Ignacio, Nadarajan, Parthiban, Bannan, Ciaran, Mallon, Patrick W., Curley, Gerard F., Preston, Roger J. S., Rehill, Aisling M., McGonagle, Dennis, Ni Cheallaigh, Cliona, Baker, Ross I., Renné, Thomas, Ward, Soracha E., O’Donnell, James S., O’Connell, Niamh, Ryan, Kevin, Kenny, Dermot, Fazavana, Judicael

“…Background Persistent symptoms including breathlessness, fatigue, and decreased exercise tolerance have been reported in patients after acute SARS‐CoV‐2…”
Get full text

The versatile heparin in COVID‐19 by Thachil, Jecko

Get full text